As of 2025-09-17, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is (4.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 97.55 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is -104.5%.
The range of the Relative Valuation is (3.45) - (3.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.9x - 7.0x | 6.5x |
| Forward P/E multiples | 7.3x - 15.3x | 12.2x |
| Fair Price | (3.45) - (3.31) | (4.40) |
| Upside | -103.5% - -103.4% | -104.5% |
| Date | P/E |
| 2025-09-16 | -207.70 |
| 2025-09-15 | -209.87 |
| 2025-09-12 | -207.53 |
| 2025-09-11 | -209.70 |
| 2025-09-10 | -207.00 |
| 2025-09-09 | -209.13 |
| 2025-09-08 | -202.20 |
| 2025-09-05 | -202.52 |
| 2025-09-04 | -203.90 |
| 2025-09-03 | -201.61 |
| 2025-09-02 | -199.87 |
| 2025-08-29 | -198.59 |
| 2025-08-28 | -196.53 |
| 2025-08-27 | -195.15 |
| 2025-08-26 | -195.17 |
| 2025-08-25 | -191.84 |
| 2025-08-22 | -193.30 |
| 2025-08-21 | -193.58 |
| 2025-08-20 | -192.47 |
| 2025-08-19 | -191.41 |
| 2025-08-18 | -190.54 |
| 2025-08-15 | -185.78 |
| 2025-08-14 | -191.16 |
| 2025-08-13 | -188.48 |
| 2025-08-12 | -187.63 |
| 2025-08-11 | -180.28 |
| 2025-08-08 | -173.06 |
| 2025-08-07 | -146.58 |
| 2025-08-06 | -146.75 |
| 2025-08-05 | -139.91 |
| 2025-08-04 | -138.97 |
| 2025-08-01 | -135.79 |
| 2025-07-31 | -134.55 |
| 2025-07-30 | -136.00 |
| 2025-07-29 | -136.36 |
| 2025-07-28 | -141.24 |
| 2025-07-25 | -143.33 |
| 2025-07-24 | -141.82 |
| 2025-07-23 | -142.09 |
| 2025-07-22 | -140.90 |
| 2025-07-21 | -138.93 |
| 2025-07-18 | -140.82 |
| 2025-07-17 | -144.52 |
| 2025-07-16 | -141.46 |
| 2025-07-15 | -135.93 |
| 2025-07-14 | -138.46 |
| 2025-07-11 | -137.97 |
| 2025-07-10 | -140.39 |
| 2025-07-09 | -138.72 |
| 2025-07-08 | -138.21 |